TY - JOUR
T1 - Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
AU - Matthews, Lucy
AU - Marasco, Rita
AU - Jenkinson, Mark
AU - Küker, Wilhelm
AU - Luppe, Sebastian
AU - Leite, Maria Isabel
AU - Giorgio, Antonio
AU - De Stefano, Nicola
AU - Robertson, Neil
AU - Johansen-Berg, Heidi
AU - Evangelou, Nikos
AU - Palace, Jacqueline
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/4/2
Y1 - 2013/4/2
N2 - Objective: Neuromyelitis optica and its spectrum disorder (NMOSD) can present similarly to relapsingremittingmultiple sclerosis (RRMS). Using a quantitative lesionmapping approach, this research aimed to identify differences in MRI brain lesion distribution between aquaporin-4 antibody-positive NMOSD and RRMS, and to test their diagnostic potential. Methods: Clinical brain MRI sequences for 44 patients with aquaporin-4 antibody-positive NMOSD and 50 patients with RRMS were examined for the distribution and morphology of brain lesions. T2 lesion maps were created for each subject allowing the quantitative comparison of the 2 conditions with lesion probability and voxel-wise analysis. Results: Sixty-three percent of patients with NMOSD had brain lesions and of these 27% were diagnostic of multiple sclerosis. Patients with RRMS were significantly more likely to have lesions adjacent to the body of the lateral ventricle than patientswith NMOSD. Direct comparison of the probability distributions and the morphologic attributes of the lesions in each group identified criteria of "at least 1 lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe; or the presence of a subcortical U-fiber lesion; or a Dawson's finger-type lesion," which could distinguish patients with multiple sclerosis from those with NMOSD with 92% sensitivity, 96% specificity, 98% positive predictive value, and 86% negative predictive value. Conclusion: Careful inspection of the distribution andmorphology ofMRI brain lesions can distinguish RRMS and NMOSD.
AB - Objective: Neuromyelitis optica and its spectrum disorder (NMOSD) can present similarly to relapsingremittingmultiple sclerosis (RRMS). Using a quantitative lesionmapping approach, this research aimed to identify differences in MRI brain lesion distribution between aquaporin-4 antibody-positive NMOSD and RRMS, and to test their diagnostic potential. Methods: Clinical brain MRI sequences for 44 patients with aquaporin-4 antibody-positive NMOSD and 50 patients with RRMS were examined for the distribution and morphology of brain lesions. T2 lesion maps were created for each subject allowing the quantitative comparison of the 2 conditions with lesion probability and voxel-wise analysis. Results: Sixty-three percent of patients with NMOSD had brain lesions and of these 27% were diagnostic of multiple sclerosis. Patients with RRMS were significantly more likely to have lesions adjacent to the body of the lateral ventricle than patientswith NMOSD. Direct comparison of the probability distributions and the morphologic attributes of the lesions in each group identified criteria of "at least 1 lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe; or the presence of a subcortical U-fiber lesion; or a Dawson's finger-type lesion," which could distinguish patients with multiple sclerosis from those with NMOSD with 92% sensitivity, 96% specificity, 98% positive predictive value, and 86% negative predictive value. Conclusion: Careful inspection of the distribution andmorphology ofMRI brain lesions can distinguish RRMS and NMOSD.
UR - http://www.scopus.com/inward/record.url?scp=84876376820&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3182887957
DO - 10.1212/WNL.0b013e3182887957
M3 - Article
C2 - 23486868
AN - SCOPUS:84876376820
VL - 80
SP - 1330
EP - 1337
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 14
ER -